PT
PIPr Therapeutics, Inc.
SEC filingBiotechnology · Durham, NC
Amount raised$1.5Msold at filing
Total offering$2.5M$1000K still open
Investors in the raise3count reported to the SEC
FiledNov 12, 2025first sale Oct 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Clay ThorpDirector
Holden ThorpDirector
Heather MadsenExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.